Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conivaptan for chronic euvolemic or hypervolemic hyponatremia
CTR20181400Phase 2Active
- Sponsor
- Furikangzheng Medical Technology
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of conivaptan in hyponatraemia, Cirrhosis, syndrome of inappropriate antidiuresis (SIAD), sponsored by Furikangzheng Medical Technology. Started Aug 2018; status: active.
02
Drugs
conivaptan
03
Conditions
hyponatraemiaCirrhosissyndrome of inappropriate antidiuresis (SIAD)
Beyond the preview
Go deeper on CTR20181400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181400.